Pal Moller

Pal Moller

UNVERIFIED PROFILE

Are you Pal Moller?   Register this Author

Register author
Pal Moller

Pal Moller

Publications by authors named "Pal Moller"

Are you Pal Moller?   Register this Author

100Publications

2022Reads

47Profile Views

From colorectal cancer pattern to the characterization of individuals at risk: Picture for genetic research in Latin America.

Int J Cancer 2019 Jul 5;145(2):318-326. Epub 2018 Dec 5.

Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.31920
Publisher Site
http://dx.doi.org/10.1002/ijc.31920DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587543PMC
July 2019

Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report.

Hered Cancer Clin Pract 2019 28;17. Epub 2019 Feb 28.

4Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, part of Oslo University Hospital, Olso, Norway.

View Article

Download full-text PDF

Source
https://hccpjournal.biomedcentral.com/articles/10.1186/s1305
Publisher Site
http://dx.doi.org/10.1186/s13053-019-0106-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394091PMC
February 2019

Causes for Frequent Pathogenic Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift.

Cancers (Basel) 2019 Jan 23;11(2). Epub 2019 Jan 23.

Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Part of Oslo University Hospital, Oslo 0424, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11020132DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406718PMC
January 2019

Cancer Risks for PMS2-Associated Lynch Syndrome.

J Clin Oncol 2018 Oct 30;36(29):2961-2968. Epub 2018 Aug 30.

Sanne W. ten Broeke, Heleen M. van der Klift, Carli M.J. Tops, Manon Suerink, Frederik J. Hes, Hans F.A. Vasen, Juul T. Wijnen, and Maartje Nielsen, Leiden University Medical Center, Leiden; Encarna Gomez Garcia, Maastricht University Medical Center, Maastricht; Nicoline Hoogerbrugge, Arjen R. Mensenkamp, and Liesbeth Spruijt, Radboud University Medical Center, Nijmegen; Tom G.W. Letteboer, University Medical Center, Utrecht; Theo A.M. van Os and Egbert J.W. Redeker, Academic Medical Center, Amsterdam; Maran J.W. Olderode-Berends and Yvonne J. Vos, University of Groningen; University Medical Center Groningen, Groningen; Anja Wagner, Erasmus Medical Center, Rotterdam, the Netherlands; Stefan Aretz, University of Bonn; University Hospital Bonn, Bonn; Christoph Engel, Leipzig University; Medizinisch Genetisches Zentrum Bayerstr, Leipzig; Magnus von Knebel Doeberitz, University of Heidelberg; German Cancer Research Center, Heidelberg; Pål Møller, University of Witten-Herdecke, Wuppertal; Nils Rahner, Heinrich-Heine-University, Düsseldorf; Hans K. Schackert, Technische Universität Dresden, Dresden; Verena Steinke-Lange, Medizinische Klinik und Poliklinik IV Campus Innenstadt, Klinikum der Universität München, Munich, Germany; Pål Møller, The Norwegian Radium Hospital; Oslo University Hospital, Oslo, Norway; Inge Bernstein, Hvidovre Hospital, Hvidovre, and Aalborg University Hospital, Aalborg, Denmark; Daniel D. Buchanan, Mark Clendenning, John L. Hopper, Mark A. Jenkins, Christophe Rosty, Ingrid Winship, and Aung Ko Win, The University of Melbourne; Daniel D. Buchanan, Ingrid Winship, and Aung Ko Win, Royal Melbourne Hospital, Parkville, Melbourne, Victoria; Rodney Scott, University of Newcastle, Newcastle, New South Wales, Australia; Albert de la Chapelle, Heather L. Hampel, Rachel Pearlman, and Leigha Senter, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Gabriel Capella and Marta Pineda, Institut d'Investigació Biomédica de Bellvitge, Barcelona, Spain; Steven Gallinger, Mount Sinai Hospital, Toronto, Ontario, Canada; Jane C. Figueiredo and Robert Haile, Cedars-Sinai Medical Center, Los Angeles, CA; Loic Le Marchand, University of Hawaii Cancer Center, Honolulu, HI; Annika Lindblom, Karolinska Institutet; Karolinska University Hospital, Stockholm, Sweden; Noralane M. Lindor, Mayo Clinic Arizona, Scottsdale, AZ; Polly A. Newcomb, Fred Hutchinson Cancer Research Center; University of Washington, Seattle, WA; and Stephen Thibodeau, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.4777
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.4777DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349460PMC
October 2018

Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation.

Gynecol Oncol 2018 07 21;150(1):85-91. Epub 2018 May 21.

Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2018.05.011DOI Listing
July 2018

Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.

Med Health Care Philos 2018 Jun;21(2):239-242

Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11019-017-9803-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956028PMC
June 2018

Retraction Note to: The variant c.68-7 T > A is associated with breast cancer.

Hered Cancer Clin Pract 2018 2;16:10. Epub 2018 May 2.

2Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13053-018-0093-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930441PMC
May 2018

Potentially pathogenic germline CHEK2 c.319+2T>A among multiple early-onset cancer families.

Fam Cancer 2018 01;17(1):141-153

Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-017-0011-0DOI Listing
January 2018

The variant c.68-7 T>A is associated with breast cancer.

Hered Cancer Clin Pract 2017 13;15:20. Epub 2017 Nov 13.

Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
https://hccpjournal.biomedcentral.com/articles/10.1186/s1305
Publisher Site
http://dx.doi.org/10.1186/s13053-017-0080-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683587PMC
November 2017

Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.

Fertil Steril 2016 Mar 14;105(3):781-785. Epub 2015 Dec 14.

Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.fertnstert.2015.11.034DOI Listing
March 2016

Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study.

Breast Cancer Res Treat 2016 Jan 16;155(2):365-73. Epub 2016 Jan 16.

Women's College Research Institute, Women's College Hospital, 76 Grenville Street, 6th Floor, Toronto, ON, M5S 1B2, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3685-3DOI Listing
January 2016

Tumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography.

Breast Cancer Res Treat 2015 Jul 3;152(1):87-94. Epub 2015 Jun 3.

Nightingale and Genesis Breast Cancer Prevention Centre, University Hospital of South Manchester NHS Foundation Trust, Wythenshawe, Manchester, M23 9LT, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-015-3448-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468806PMC
July 2015

Ten modifiers of BRCA1 penetrance validated in a Norwegian series.

Hered Cancer Clin Pract 2015 30;13(1):14. Epub 2015 May 30.

Research Group on Inherited Cancer, Department of Medical Genetics, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13053-015-0035-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456774PMC
June 2015

Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.

J Clin Oncol 2015 Feb 15;33(4):319-25. Epub 2014 Dec 15.

Sanne W. ten Broeke, Carli M. Tops, Heleen M. van der Klift, Manon Suerink, Frederik J. Hes, Hans F. Vasen, Maartje Nielsen, and Juul T. Wijnen, Leiden University Medical Center; Hans F. Vasen, The Netherlands Foundation for the Detection of Hereditary Tumors, Leiden; Richard M. Brohet, Research Center Linnaeus Institute, Spaarne Hospital, Hoofddorp; Mary E. Velthuizen and Tom G.W. Letteboer, University Medical Center Utrecht, Utrecht; Encarna Gomez Garcia, Maastricht University Medical Center, Maastricht; Nicoline Hoogerbrugge, Arjen R. Mensenkamp, and Liesbeth Spruijt, Radboud University Medical Center, Nijmegen; Fred H. Menko, Vrije Universiteit, University Medical Center; Theo A. van Os and Bert J.W. Redeker, Academic Medical Center, Amsterdam; Rolf H. Sijmons and Yvonne J. Vos, University of Groningen, University Medical Center Groningen, Groningen; Anja Wagner, Erasmus University Medical Center, Rotterdam, the Netherlands; Inge Bernstein, Aalborg University Hospital, Aalborg; Inge Bernstein, Danish Hereditary Nonpolyposis Colorectal Cancer Registry, Hvidovre University Hospital Copenhagen, Denmark; Gabriel Capellá Munar, Hereditary Cancer Program, Catalan Institute of Oncology-Institut D'Investigació Biomèdica de Bellvitge, l'Hospitalet de Llobregat, Spain; Annika Lindblom, Karolinska Institutet, Karolinska University Hospital, Solna; Pal Moller, Research Group Inherited Cancer, Oslo University Hospital, Oslo, Norway; and Nils Rahner, Institute of Human Genetics, University of Dusseldorf, Dusseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.8088DOI Listing
February 2015

MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis.

Breast Cancer Res Treat 2014 Dec 15;148(3):687-8. Epub 2014 Nov 15.

Department of Mathematics, University of Oslo, Blindern, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-3178-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243005PMC
December 2014

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.

J Clin Oncol 2014 May 24;32(15):1547-53. Epub 2014 Feb 24.

Amy P.M. Finch, Barry Rosen, Andrea Eisen, Kelly A. Metcalfe, Islay Thompson, Joan Murphy, Ping Sun, and Steven A. Narod, University of Toronto; Barry Rosen and Joan Murphy, Princess Margaret Hospital; Amy P.M. Finch, Islay Thompson, Ping Sun, and Steven A. Narod, Women's College Research Institute; Andrea Eisen, Sunnybrook Odette Cancer Center, Toronto; Peter Ainsworth, London Regional Cancer Program, London, Ontario; Parviz Ghadirian, University of Montreal Hospital Centre; William D. Foulkes, McGill University, Montreal, Quebec; Charmaine Kim-Sing, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Jan Lubinski, Cezary Cybulski, and Tomasz Huzarski, Pomeranian Medical University, Szczecin, Poland; Pål Møller and Lovise Maehle, Norwegian Radium Hospital and Oslo University Hospital, Oslo, Norway; Christian F. Singer, Medical University of Vienna, Vienna, Austria; Beth Karlan, Cedars-Sinai Medical Center, Beverly Hills; Susan Neuhausen, City of Hope National Medical Center, Duarte, CA; Leigha Senter, Ohio State University Medical Center, Columbus, OH; Nadine Tung, Beth Israel Deaconess Medical Center, Boston, MA; and Henry T. Lynch, Creighton University School of Medicine, Omaha, NE.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.2820DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026578PMC
May 2014

The Norwegian PMS2 founder mutation c.989-1G > T shows high penetrance of microsatellite instable cancers with normal immunohistochemistry.

Hered Cancer Clin Pract 2014 21;12(1):12. Epub 2014 Apr 21.

Department of Pathology and Medical Genetics, St. Olavs University Hospital, Trondheim, Norway ; Department of Laboratory Medicine Children's and Women's Health, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1897-4287-12-12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005455PMC
May 2014

The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation.

Breast Cancer Res Treat 2014 Apr 12;144(3):607-14. Epub 2014 Mar 12.

Inherited Cancer Research Group, Department for Medical Genetics, The Norwegian Radium Hospital, Oslo University Hospital, 0310, Oslo, Norway,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2902-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962741PMC
April 2014

Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program.

Breast Cancer Res Treat 2013 May 25;139(1):155-61. Epub 2013 Apr 25.

Inherited Cancer Research Group, Department for Medical Genetics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2540-zDOI Listing
May 2013

[Sperm mutations and older fathers].

Authors:
Pål Møller

Tidsskr Nor Laegeforen 2013 Mar;133(6):609

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4045/tidsskr.13.0253DOI Listing
March 2013

A SImplified method for Segregation Analysis (SISA) to determine penetrance and expression of a genetic variant in a family.

Hum Mutat 2011 May 22;32(5):568-71. Epub 2011 Feb 22.

Section for Cancer Genetics, Department of Genetics, Radiumhosptialet, Oslo University Hospital, N-0310 Oslo, Norway.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/humu.21441
Publisher Site
http://dx.doi.org/10.1002/humu.21441DOI Listing
May 2011

CGEN--a Clinical GENetics software application.

Hum Mutat 2011 May 8;32(5):537-42. Epub 2011 Mar 8.

Norwegian Radium Hospital, Section of Cancer Genetics, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.21452DOI Listing
May 2011

Fanconi anaemia, BRCA2 and familial considerations - follow up on a previous case report.

Acta Paediatr 2010 Nov;99(11):1741-3

Section for Inherited Cancer, Department of Medical Genetics, Radiumhospitalet, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1651-2227.2010.01929.x
Publisher Site
http://dx.doi.org/10.1111/j.1651-2227.2010.01929.xDOI Listing
November 2010

High penetrances of BRCA1 and BRCA2 mutations confirmed in a prospective series.

Hered Cancer Clin Pract 2010 Jan 19;8(1). Epub 2010 Jan 19.

Section of Cancer Genetics, The Norwegian Radium Hospital, Oslo University Hospital, N-0310 Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1897-4287-8-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828412PMC
January 2010

High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR-mutation carriers.

Fam Cancer 2009 8;8(2):145-51. Epub 2008 Oct 8.

Section for Inherited Cancer, Department of Medical Genetics, Rikshospitalet Medical Centre, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-008-9219-3DOI Listing
September 2009

Germ-line mutations in mismatch repair genes associated with prostate cancer.

Cancer Epidemiol Biomarkers Prev 2009 Sep 1;18(9):2460-7. Epub 2009 Sep 1.

Section for Inherited Cancer, Department of Medical Genetics, Rikshospitalet University Hospital, N-0310 Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-09-0058DOI Listing
September 2009

Survival in Norwegian BRCA1 mutation carriers with breast cancer.

Hered Cancer Clin Pract 2009 Apr 14;7(1). Epub 2009 Apr 14.

Institute of clinical medicine, University of Bergen, N-5021 Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1897-4287-7-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678098PMC
April 2009

Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast/ovarian cancer.

Fam Cancer 2008 25;7(3):245-54. Epub 2008 Jan 25.

Section for Hereditary Cancer, Department for Medical Genetics, Rikshospitalet-Radiumhospitalet Medical Center, 0310, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-008-9182-zDOI Listing
January 2009

High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers.

Clin Cancer Res 2008 Nov;14(22):7569-73

Section for Inherited Cancer, Department of Medical Genetics, Rikshospitalet University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-08-0112DOI Listing
November 2008

Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation status.

Int J Cancer 2007 Sep;121(5):1017-20

Section for Inherited Cancer, Department of Medical Genetics, Rikshospitalet-Radiumhospitalet Clinical Center, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.22789DOI Listing
September 2007

Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series.

Breast 2007 Aug 21;16(4):367-74. Epub 2007 Feb 21.

Department of Circulation and Medical Imaging, the Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S096097760700024
Publisher Site
http://dx.doi.org/10.1016/j.breast.2007.01.006DOI Listing
August 2007

Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers.

Eur J Cancer 2007 Jul 15;43(11):1713-7. Epub 2007 Jun 15.

Section for Inherited Cancer, Department of Medical Genetics, Rikshospitalet-Radiumhospitalet Medical Centre, N-0310 Oslo, Norway.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S095980490700350
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2007.04.023DOI Listing
July 2007

No sib pair concordance for breast or ovarian cancer in BRCA1 mutation carriers.

Hered Cancer Clin Pract 2007 Jun 15;5(2):67-71. Epub 2007 Jun 15.

Section for Inherited Cancer, Department of Medical Genetics, Rikshospitalet-Radiumhospitalet Medical Center Oslo, Norway.

View Article

Download full-text PDF

Source
http://hccpjournal.biomedcentral.com/articles/10.1186/1897-4
Publisher Site
http://dx.doi.org/10.1186/1897-4287-5-2-67DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736994PMC
June 2007

Amplification of TOP2A and HER-2 genes in breast cancers occurring in patients harbouring BRCA1 germline mutations.

Acta Oncol 2007 ;46(2):199-203

Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1080/0284186060094955
Publisher Site
http://dx.doi.org/10.1080/02841860600949552DOI Listing
June 2007

Prevention of colorectal cancer by colonoscopic surveillance in families with hereditary colorectal cancer.

Scand J Gastroenterol 2007 May;42(5):611-7

Section of Genetic Counselling, Department of Cancer Genetics, Rikshospitalet-Radiumhospitalet Medical Centre, Oslo, Norway.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1080/0036552060101023
Publisher Site
http://dx.doi.org/10.1080/00365520601010230DOI Listing
May 2007

The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study.

Gynecol Oncol 2007 Jan 8;104(1):7-10. Epub 2006 Sep 8.

Centre for Research in Women's Health, 790 Bay Street, Toronto, ON, Canada M5G 1N8.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009082580600618
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2006.08.004DOI Listing
January 2007

Germline PTEN mutations are rare and highly penetrant.

Hered Cancer Clin Pract 2006 Dec 15;4(4):177-85. Epub 2006 Dec 15.

Section for Inherited Cancer, Department of Medical Genetics, Rikshospitalet-Radiumhospitalet Medical Centre, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1897-4287-4-4-177DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837306PMC
December 2006

Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics.

Hum Genet 2006 Nov 25;120(4):471-85. Epub 2006 Aug 25.

Harwick 7, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00439-006-0219-9DOI Listing
November 2006

[Increased incidence of testicular dysgenesis?].

Authors:
Pål Møller

Tidsskr Nor Laegeforen 2006 Oct;126(20):2688; author reply 2688

View Article

Download full-text PDF

Source
October 2006

[Handling of hereditary intestinal cancer].

Tidsskr Nor Laegeforen 2006 Aug;126(15):1937-9

Norsk gruppe for arvelig kreft, Seksjon for arvelig kreft, Avdeling for medisinsk genetikk, Rikshospitalet-Radiumhospitalet, 0310 Oslo.

View Article

Download full-text PDF

Source
August 2006

MUTYH Mutations Do Not Cause HNPCC or Late Onset Familial Colorectal Cancer.

Hered Cancer Clin Pract 2006 May 15;4(2):90-3. Epub 2006 May 15.

Section for Inherited Cancer, Department for Medical Genetics, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1897-4287-4-2-90DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837291PMC
May 2006

Quality of life and its relation to cancer-related stress in women of families with hereditary cancer without demonstrated mutation.

Qual Life Res 2006 Apr;15(3):461-70

Section for Genetic Counselling, Department of Cancer Genetics, Rikshospitalet-Radiumhospitalet Trust, 0310, Montebello, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11136-005-3008-3DOI Listing
April 2006

Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.

Gynecol Oncol 2006 Jan 31;100(1):83-8. Epub 2005 Aug 31.

Centre for Research in Women's Health, 790 Bay Street, 7th Floor, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada M5G 1N8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2005.07.110DOI Listing
January 2006

Estimated prevalence of hereditary cancers and the need for surveillance in a Norwegian county, Telemark.

Scand J Gastroenterol 2006 Jan;41(1):71-9

Section of Genetic Counselling, Department of Cancer Genetics, The Norwegian Radium Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00365520510023891DOI Listing
January 2006

[Hereditary breast cancer].

Tidsskr Nor Laegeforen 2005 Nov;125(22):3136-8

Norsk gruppe for arvelig kreft Seksjon for genetisk veiledning Radiumhospitalet 0310 Oslo.

View Article

Download full-text PDF

Source
November 2005

A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics.

Am J Hum Genet 2005 Aug 29;77(2):219-29. Epub 2005 Jun 29.

Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/432377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224525PMC
August 2005

Immunohistochemistry identifies carriers of mismatch repair gene defects causing hereditary nonpolyposis colorectal cancer.

J Clin Oncol 2005 Jul;23(21):4705-12

Section of Genetic Counselling, Department of Cancer Genetics, The Norwegian Radium Hospital, N-0310 Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.05.180DOI Listing
July 2005